MS Clinic Mauricie Bois Francs

Trois-Rivières, Quebec G8Z 3R9

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed